OKLAHOMA CITY–(BUSINESS WIRE)–EyeCRO is thrilled to announce that groundbreaking data from the first clinical application of its innovative MiDROPS® platform technology is being presented by Telios Pharma at the 96th meeting of the Association for Re…
Author: Business Wire
Eye2Gene and Heidelberg Engineering Announce Collaborative Partnership at ARVO 2024
SEATTLE–(BUSINESS WIRE)–Eye2Gene™, a pioneering artificial intelligence National Institute for Health and Care Research (NIHR) funded project based at the University College London Institute of Ophthalmology and Moorfields Eye Hospital, and Heidelber…
Baxter Declares Quarterly Dividend
DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on July 1, 2…
OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
EyeCare Partners Announces Refinancing Transaction Completion
ST. LOUIS–(BUSINESS WIRE)–EyeCare Partners announced it has closed a follow-on debt exchange with holders of its existing term loans.
Toku welcomes Dr Robert Weinreb to Board of Directors
SAN DIEGO–(BUSINESS WIRE)–Toku is pleased to announce the appointment of Robert N. Weinreb MD to its Board of Directors. Renowned globally for his contributions to ophthalmology, Dr. Weinreb’s appointment underscores Toku’s commitment to excellence a…
EyeCare Partners Announces Joel Day as New Chief Financial Officer
ST. LOUIS–(BUSINESS WIRE)–EyeCare Partners announced Joel Day will take the Chief Financial Officer role, effective June 1.
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “company” or “Viridian”), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announce…
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2024 after market close on Thursday, May 9, 2024 and will hold an investment c…
RevolutionEHR Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List
SAN DIEGO–(BUSINESS WIRE)–RevolutionEHR has been awarded Newsweek’s “World’s Best Digital Health Companies 2024.” This recognition is presented by Newsweek and Statista Inc.
Corning Announces Quarterly Dividend
CORNING, N.Y.–(BUSINESS WIRE)—- $GLW #CorningIncorporated–Corning Incorporated’s (NYSE: GLW) Board of Directors today declared a quarterly dividend of $0.28 per share. The dividend will be payable on June 27, 2024, to shareholders of record on May …
Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessment
UPPSALA, Sweden–(BUSINESS WIRE)–Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® Generic Rodent Anti-Drug Anti…
The 22nd Annual OneLegacy Run/Walk Closes Donate Life Month Celebrations Gathering Thousands of Donor Families, Grateful Recipients and Donation Advocates at Azusa Pacific University to Honor the Gift of Life
LOS ANGELES–(BUSINESS WIRE)–Nearly 4,000 deceased donor families and friends, transplant recipients and donation advocates touched by the power of organ, eye and tissue donation gathered last Saturday, April 27 at Azusa Pacific University to celebrat…
Ora and Singapore Eye Research Institute Unveil Groundbreaking Partnership to Propel Ophthalmology Innovation Globally
BOSTON & SINGAPORE–(BUSINESS WIRE)– #innovation–Ora announces exclusive partnership with Singapore Eye Research Institute (SERI), world-renowned for cutting-edge research, preclinical studies.
Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the Company’s first quarte…
Baxter Reports First-Quarter 2024 Results
DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024. “Baxter’s results in the first quarter reflect the company’s solid operational performance, fueled by…
Drug Farm Announces anti-HBV immunomodulator, DF-006 is Accepted as a Late-Breaking Presentation at the 2024 European Association for the Study of the Liver Conference
GUILFORD, Conn.–(BUSINESS WIRE)–Drug Farm, a private biotechnology company utilizing genetics and artificial intelligence technologies to discover and develop innovative, immune-modulating therapies, today announced that the chronic hepatitis B patie…
Isarna Therapeutics Announces Phase 2 Clinical Data Presentations at Upcoming Ophthalmology Conferences
MUNICH–(BUSINESS WIRE)–Isarna Therapeutics today announced upcoming oral presentations at the OIS Retina Innovation Summit on May 4th and the Association for Research in Vision and Ophthalmology (ARVO) Meeting on May 7th, both in Seattle, WA. Isarna’…
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted two newly-hired non-executive employees stock options to purchase …